WENDY KEITEL to Anthrax Vaccines
This is a "connection" page, showing publications WENDY KEITEL has written about Anthrax Vaccines.
Connection Strength
1.840
-
Evaluation of a plasmid DNA-based anthrax vaccine in rabbits, nonhuman primates and healthy adults. Hum Vaccin. 2009 Aug; 5(8):536-44.
Score: 0.330
-
Recombinant protective antigen 102 (rPA102): profile of a second-generation anthrax vaccine. Expert Rev Vaccines. 2006 Aug; 5(4):417-30.
Score: 0.267
-
Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019. MMWR Recomm Rep. 2019 12 13; 68(4):1-14.
Score: 0.169
-
Progress toward the Development of a NEAT Protein Vaccine for Anthrax Disease. Infect Immun. 2016 Dec; 84(12):3408-3422.
Score: 0.136
-
Humoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans. Clin Vaccine Immunol. 2016 Apr; 23(4):326-38.
Score: 0.131
-
Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial. Vaccine. 2014 Jun 12; 32(28):3548-54.
Score: 0.114
-
Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial. Vaccine. 2014 Feb 12; 32(8):1019-28.
Score: 0.112
-
Assessing agreement of repeated binary measurements with an application to the CDC's anthrax vaccine clinical trial. Int J Biostat. 2013 Jul 27; 9(1).
Score: 0.108
-
Health-related quality of life in the CDC Anthrax Vaccine Adsorbed Human Clinical Trial. Vaccine. 2012 Aug 31; 30(40):5875-9.
Score: 0.101
-
Frequency and domain specificity of toxin-neutralizing paratopes in the human antibody response to anthrax vaccine adsorbed. Infect Immun. 2009 May; 77(5):2030-5.
Score: 0.080
-
Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial. JAMA. 2008 Oct 01; 300(13):1532-43.
Score: 0.078
-
Domain specificity of the human antibody response to Bacillus anthracis protective antigen. Vaccine. 2008 Jul 29; 26(32):4041-7.
Score: 0.076
-
Response to letter to the editor "Zink TK. Vaccine 2007;25(15):2766-7". Vaccine. 2007 Oct 16; 25(42):7285-7.
Score: 0.072
-
Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial. Vaccine. 2006 Aug 14; 24(33-34):5950-9.
Score: 0.066